POELF (POELF)

The S&P 500 earnings growth jumped to 47.4% in the second quarter as technology companies like Amazon lead the charge

Earnings from big U.S. companies and closely-watched jobs reports are among the key updates for Wall Street this week.

AMD’s latest quarterly results are set to be released Tuesday afternoon, with traders anticipating a big move from the chipmaker’s stock.

At first glance, Pfizer (PFE +0.40%) looks like a great stock to buy. The company has a reliable dividend program and regularly raises its payouts, boasting a 6.8% forward yield, well above the S&P 500's average of 1.1%. Further, Pfizer trades at 8.5x forward earnings versus 18.8x for healthcare ...

The average brokerage recommendation (ABR) for Powell Industries (POWL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?